Physicians question usability of wearable device data

The proliferation of wearable devices is giving physicians some pause about the usability of the data they collect, reports NPR.

Just because a device looks shiny and new doesn't mean it's useful or accurate. "I get information from watching people's body language, tics and tone of voice. Subtleties you just can't get from a Fitbit or some kind of health app," said Paul Abramson, MD, in the story. 

Read more below:

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.